Literature DB >> 30509741

PD-1 antibodies in head-and-neck cancer.

Barbara Wollenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30509741     DOI： 10.1016/S0140-6736(18)32346-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer.

Authors:  Bo Lin; Hao Li; Tianwen Zhang; Xin Ye; Hongyu Yang; Yuehong Shen
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

2.  Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy.

Authors:  Si-Yuan Zhang; Xian-Yue Ren; Chun-Yang Wang; Xi-Juan Chen; Ruo-Yan Cao; Qin Liu; Xue Pan; Jia-Ying Zhou; Wei-Lin Zhang; Xin-Ran Tang; Bin Cheng; Tong Wu
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

3.  Soluble PD-L1 improved direct ARDS by reducing monocyte-derived macrophages.

Authors:  Jing Xu; Jiahui Wang; Xiaoli Wang; Ruoming Tan; Xiaoling Qi; Zhaojun Liu; Hongping Qu; Tingting Pan; Qingyuan Zhan; Yong Zuo; Wen Yang; Jialin Liu
Journal:  Cell Death Dis       Date:  2020-10-30       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.